The findings add complexity to questions about the long-term impact of acute lymphoblastic leukemia (ALL) therapy. A new report shows high cumulative doses of intravenous methotrexate can have ...

Dr Jagannathan highlighted five specific classes of drugs that patients and physicians should monitor closely for ...

A new model can predict which patients are more likely to experience side effects from long-term methotrexate (MTX) use, research suggests. Patients with a lower risk profile may benefit from less ...

Please provide your email address to receive an email when new articles are posted on . Patients with RA treated with first-line upadacitinib over 5 years had greater reductions in disease activity vs ...